4//SEC Filing
Ragan Paula 4
Accession 0001628280-24-042941
CIK 0001501697other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:54 PM ET
Size
5.4 KB
Accession
0001628280-24-042941
Insider Transaction Report
Form 4
Ragan Paula
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-10-15$0.56/sh−31,897$17,926→ 1,025,816 total
Footnotes (2)
- [F1]These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 28, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.5424 to $0.5806, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001769914
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:54 PM ET
- Size
- 5.4 KB